Pneumonia lipóide

Kissmann, Gunther; Zamboni, Mauro; Monteiro, Andreia Salarini; Sousa, Aureliano M Cavalcanti de; Nascimento, Marilene Batista da Cruz; Esteves, Mauro; Biasi, Paulo de; Lannes, Deborah Cordeiro

doi:10.1016/s2173-5115(08)70283-5

Cited by 1 publication

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fat could enter the lungs exogenously through the mouth and nose, which is also called exogenous lipoid pneumonia, or could be accumulated endogenously in the lungs [1]. It seems that the inability of macrophages to gather cholesterol collected in the alveoli due to the destruction of the type-II pneumocytes results in the endogenous accumulation of fat in the lungs [2]. The accumulation of fat in the lung tissue causes fibroblastic inflammation of the interstitial lung tissue, which can lead to progressive dyspnea and, in some cases, respiratory failure.…”

Section: Introductionmentioning

confidence: 99%

Adult Onset Still Disease Associated with Endogenous Lipoid Pneumonia

Sami

Zohal

Mohammadi

2019

Advances in Respiratory Medicine

View full text Add to dashboard Cite

Cholesterol pneumonia or endogenous lipid pneumonia (ELP) is a rare disease that can occur in the context of a systemic disease or following a bronchial obstruction. It is characterized by a wide range of diverse symptoms and various disease course. The present report introduces a young woman diagnosed with adult onset still disease three years ago, who has been referred with macrophage activation syndrome (MAS). She underwent biopsy due to dyspnea and a crazy paving pattern in HRCT of the lungs, leading to the diagnosis of lipoid pneumonia based on the interstitial lymphocytic inflammation and cholesterol granulomas. So far, there has been no report indicating MAS associated with cholesterol pneumonia. This is the second case reporting ELP in the adult onset still disease.

show abstract

Section: Introductionmentioning

confidence: 99%